This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
19 - 21 October, 2026
The Westin Miyako KyotoKyoto, Japan
BOOK NOW
Menu
BOOK NOW

Vladimir Bobkov, PhD
Principal Scientist at argenx, Belgium
Speaker

Profile

Principal Scientist at argenx with a broad background in antibody discovery and engineering, driving programs from mechanistic preclinical research into early clinical POC studies

Agenda Sessions

  • Step-Wise Optimization of a Next Generation FcRn Inhibitor Fused to an Albumin-Binder for Improved IgG Clearance

    , 11:30
    View Session

At this event

Prev
Next
Taichi Kuramochi
Head of Biologics Discovery
Chugai Pharmaceutical, Japan

See Vladimir at Antibody Engineering & Therapeutics Asia

BOOK NOW